Abstract
This study describes serum levels of soluble interleukin-2 receptor (sIL-2R) in 13 healthy women, 10 women with breast dysplasia and 37 patients with breast carcinoma. A difference was found between sIL-2R levels in normal women and cancer patients. sIL-2R increased with the advance in stage of cancer but the extent of increase fell from stage III to stage IV as compared to the change from stage II to stage III. Of the 15 patients who were followed after surgery and/or therapy, 10 (67%) showed a fall in the serum sIL-2R levels. A negative correlation was found between sIL-2R levels and lymphocytic infiltration only within the malignant tissue. These findings probably indicate that sIL-2R exerts an immunomodulatory effect on blood lymphocytes by preventing their infiltration into the tumour tissue. To our knowledge, this is the first report of its kind in immunology of breast carcinoma.
Key words: Serum soluble interleukin-2 receptor, Breast carcinoma, Lymphocyte infiltration
References
- 1.Abrol SK, Shinghal RN, Saha K. Cellular immunity and prognosis of human mammary carcinoma. Indian J Med Res. 1984;79:199. [PubMed] [Google Scholar]
- 2.Cobleigh MA, Braun DP, Harris JE. Quantitation of lymphocytes and T-cell subsets in patients with disseminated cancer. J Natl Cancer Inst. 1980;64:1041. [PubMed] [Google Scholar]
- 3.Goust JM, Roof BS, Fudenberg HH, O'Brien PH. T-cell markers in breast cancer patients at diagnosis. Clin Immunol Immunopathol. 1979;12:396. doi: 10.1016/0090-1229(79)90044-8. [DOI] [PubMed] [Google Scholar]
- 4.Hermann E, Cannistra SA, Levine H, Griffin JD. Expression of interleukin-2 receptors and binding of interleukin-2 by γ-interferon induced human leukemic and normal monocytic cells. J Exp Med. 1985;162:1111. doi: 10.1084/jem.162.3.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.International Union against Cancer . TNM classification of malignant tumours. 3rd edn. Geneva: IUCC; 1982. [Google Scholar]
- 6.Kloster BE, John PA, Miller LE, Rubin LA, Nelson DL, Blair DC, Tomar RH. Soluble interleukin-2 receptors are elevated in patients with AIDS or at risk of developing AIDS. Clin Immunol Immunopathol. 1987;45:440. doi: 10.1016/0090-1229(87)90095-x. [DOI] [PubMed] [Google Scholar]
- 7.Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndrome. Blood. 1989;73:2128. [PubMed] [Google Scholar]
- 8.Lang JM, Coumaros G, Levy S, Falkenrodt A, Steckmeyer M, Partisani M, Alcksijevic A, Lehr L, Koehl C. Elevated serum levels of soluble interleukin-2 receptors in HIV infection: correlation studies with markers of cell activation. Immunol Lett. 1988;19:99. doi: 10.1016/0165-2478(88)90126-5. [DOI] [PubMed] [Google Scholar]
- 9.Mackween L, Brown M, Ip SH, Kung PC, Yasuda N, Harrington D, Hinuma Y, Weisenburger D, Lai P, Purtilo D. Serum interleukin-2 receptor as a marker for active T cell malignancies. Fed Proc. 1986;45:454. [Google Scholar]
- 10.Mehra V, Convit J, Rubinstein A, Bloom BB. Activated suppressor T cells in leprosy. J Immunol. 1982;129:1946. [PubMed] [Google Scholar]
- 11.Nelson DL. Soluble interleukin-2 receptors analysis in normal individuals and in certain disease states. Fed Proc. 1986;45:377. [Google Scholar]
- 12.Nemoto T, Han T, Minowada J, Angkor V, Chambertain WA, Dad TL. Cell-mediated immune status of breast cancer patients, evaluation by skin tests, lymphocyte stimulation and counts of rosette forming cells. J Natl Cancer Inst. 1974;53:641. doi: 10.1093/jnci/53.3.641. [DOI] [PubMed] [Google Scholar]
- 13.Pui CH, Ip SH, Ilfah S, Behm FG, Grose BH, Dodge RK, Cristy WM, Furman WL, Murphy SB, Rivera GK. Serum interleukin-2 receptor levels in childhood acute lymphoblastic leukemia. Blood. 1988;71:1135. [PubMed] [Google Scholar]
- 14.Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985;135:3172. [PubMed] [Google Scholar]
- 15.Saha K, Kapila H, Madan R, Shinghal RN. Immunologic tools to decipher efficacy of BCG immunotherapy in advanced breast cancer. A one year followup study. Asian Pac J Allergy Immunol. 1986;4:139. [PubMed] [Google Scholar]
- 16.Tsudo M, Uchiyama T, Uchino H. Expression of Tac antigen on activated normal human B cells. J Exp Med. 1984;160:612. doi: 10.1084/jem.160.2.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tung KSR, Umland E, Matzner P, Nelson K, Schanf V, Rubin I, Wagner D, Scollard D, Vithayasai P, Vithayasai V, Worobec S, Smith T, Suriyanond V. Soluble serum interleukin-2 receptor levels in leprosy patients. Clin Exp Immunol. 1987;68:10. [PMC free article] [PubMed] [Google Scholar]
- 18.Uchiyama T, Nelson DL, Fleisher LA, Waldmann LA. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells: II. Expression of Tac antigens on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol. 1981;126:1398. [PubMed] [Google Scholar]
- 19.Waldmann TA, Goldman CK, Robb JR, Depper JM, Leonard WJ, Sharrow SO, Bongiovanni KF, Korsmeyer SJ, Greene WC. Expression of interleukin-2 receptors on activated human B cells. J Exp Med. 1984;160:1450. doi: 10.1084/jem.160.5.1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Yasuda N, Lai PK, Ip SH, Kung PC, Himuma Y, Matsuoka M, Hatteri T, Takatsuki K, Purtilo LT. Soluble interleukin-2 receptors in sera of Japanese patients with adult T-cell leukemia mark activity of disease. Blood. 1988;71:1021. [PubMed] [Google Scholar]